EUVIMEDEUVIMED entdecken
Crossref

Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition

Lu-Jun Zhang, Yang-Xi Hu, Rong-Zhong Huang, Yan-Yan Xu, Shao-Hua Dong, Fang-Hao Guo, Jun-Jun Guo, Jing-Jing Qiu, Zi-Yun Cao, Li-Jiang Wei, Jia-Hao Mao, Ankang Lyu und 4 weitere

Cardiovascular Research · 2024

DOI: 10.1093/cvr/cvae138 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2024. Verfasst von Lu-Jun Zhang und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai Changhai Hospital, 168 Changhai Road, Shanghai 200433, China. Hauptthemen laut MEDLINE: Blood Platelets, Disease Models, Animal, MicroRNAs, Myocardial Infarction. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

MicroRNA-126 (miR-126), one of the most abundant microRNAs in platelets, is involved in the regulation of platelet activity and the circulating miR-126 is reduced during antiplatelet therapy. However, whether intraplatelet miR-126 plays a role in thrombosis and platelet inhibition remains unclear. Methods and results Here, using tissue-specific knockout mice, we reported that the deficiency of miR-126 in platelets and vascular endothelial cells significantly prevented thrombosis and prolonged bleeding time. Using chimeric mice, we identified that the lack of intraplatelet miR-126 significantly prevented thrombosis. Ex vivo experiments further demonstrated that miR-126-deficient platelets displayed impaired platelet aggregation, spreading, and secretory functions. Next, miR-126 was confirmed to target phosphoinositol-3 kinase regulatory subunit 2 (PIK3R2) in platelet, which encodes a negative regulator of the phosphoinositide 3-kinase/protein kinase B pathway, enhancing platelet activation through activating the integrin αIIbβ3-mediated outside-in signalling. After undergoing myocardial infarction (MI), chimeric mice lacking intraplatelet miR-126 displayed reduced microvascular obstruction and prevented MI expansion in vivo. In contrast, overexpression of miR-126 by the administration of miR-126 agonist (agomiR-126) in wild-type mice aggravated microvascular obstruction and promoted MI expansion, which can be almost abolished by aspirin administration. In patients with cardiovascular diseases, antiplatelet therapies, either aspirin alone or combined with clopidogrel, decreased the level of intraplatelet miR-126. The reduction of intraplatelet miR-126 level was associated with the decrease in platelet activity.

Conclusion

Our murine and human data reveal that (i) intraplatelet miR-126 contributes to platelet activity and promotes thrombus formation, and (ii) the reduction of intraplatelet miR-126 contributes to platelet inhibition during antiplatelet therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsDisease Models, AnimalMicroRNAsMyocardial InfarctionPlatelet AggregationPlatelet Aggregation InhibitorsSignal TransductionThrombosisAnimalsHumansMaleAspirinBleeding TimeCells, CulturedClopidogrelHuman Umbilical Vein Endothelial CellsMice, Inbred C57BLMice, KnockoutPhosphatidylinositol 3-KinasesPlatelet ActivationProto-Oncogene Proteins c-akt

Stichwörter der Autor:innen

PIK3R2PlateletPlatelet inhibitionThrombosismiR-126

Substanzen

AspirinClopidogrelMicroRNAsMIRN126 microRNA, humanMIRN126 microRNA, mousePhosphatidylinositol 3-Kinasesphosphoinositol-3 kinase regulatory subunit 2, humanPlatelet Aggregation InhibitorsProto-Oncogene Proteins c-akt

Autor:innen und Institutionen

  • Department of Cardiology, Shanghai Changhai Hospital, 168 Changhai Road, Shanghai 200433, China.
  • Department of Cardiology, Shanghai Changzheng Hospital, Shanghai, China.
  • Department of Geriatrics, Second Hospital Affiliated to Chongqing Medical University, Chongqing Medical University, Chongqing, China.
  • Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory of Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • CAS Key Laboratory of Tissue Microenvironment and Tumor, Innovation Center for Intervention of Chronic Disease and Promotion of Health, Shanghai Institute of Nutrition and Health, University of Chinese Academy of Scienc…
  • Department of Cardiology, Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

ORCID-Profile: Zhi-Fu Guo, Qing Jing

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China

Zitieren

APA

Zhang, L. J., Hu, Y. X., Huang, R. Z., Xu, Y. Y., Dong, S. H., Guo, F. H., Guo, J. J., Qiu, J. J., Cao, Z. Y., Wei, L. J., Mao, J. H., Lyu, A., Liu, J. L., Zhao, X. X., Guo, Z. F., & Jing, Q. (2024). Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition. Cardiovascular Research. https://doi.org/10.1093/cvr/cvae138

Vancouver

Zhang LJ, Hu YX, Huang RZ, Xu YY, Dong SH, Guo FH, et al. Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition. Cardiovascular Research. 2024. doi:10.1093/cvr/cvae138

BibTeX
@article{Zhang2024,
  author = {Zhang, Lu-Jun and Hu, Yang-Xi and Huang, Rong-Zhong and Xu, Yan-Yan and Dong, Shao-Hua and Guo, Fang-Hao and Guo, Jun-Jun and Qiu, Jing-Jing and Cao, Zi-Yun and Wei, Li-Jiang and Mao, Jia-Hao and Lyu, Ankang and Liu, Jun-Ling and Zhao, Xian-Xian and Guo, Zhi-Fu and Jing, Qing},
  title = {Intraplatelet miRNA-126 regulates thrombosis and its reduction contributes to platelet inhibition},
  journal = {Cardiovascular Research},
  year = {2024},
  doi = {10.1093/cvr/cvae138}
}
Kostenlos starten →